Works by Xudong Zhang


Results: 629
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44

    Fotemustine-based therapy in combination with rituximab as a first-line induction chemotherapy followed by WBRT for newly diagnosed primary central nervous system lymphoma: a prospective phase II trial.

    Published in:
    Cancer Biology & Medicine, 2022, v. 19, n. 7, p. 1089, doi. 10.20892/j.issn.2095-3941.2021.0026
    By:
    • Jingjing Wu;
    • Fenghua Gao;
    • Wenhua Wang;
    • Xudong Zhang;
    • Meng Dong;
    • Lei Zhang;
    • Xin Li;
    • Ling Li;
    • Zhenchang Sun;
    • Xinhua Wang;
    • Xiaorui Fu;
    • Linan Zhu;
    • Mengjie Ding;
    • Songtao Niu;
    • Zhaoming Li;
    • Yu Chang;
    • Feifei Nan;
    • Jiaqian Yan;
    • Hui Yu;
    • Xiaolong Wu
    Publication type:
    Article
    45
    46
    47
    48
    49
    50